In aggregate, these findings indicate that obesity is associated with an increased risk of recurrence for HER2+ breast cancers in patients, a conclusion that is consistent with our observations in mice and that further supports the utility of this model. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.